How to Join This Clinical Trial - NCTNCT04291885
Learn how to participate in this PHASE2 trial studying an investigational therapy for Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III, Neuroendocrine Tumors, Carcinoma Neuroendocrine Skin. Current status: ACTIVE_NOT_RECRUITING.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III, Neuroendocrine Tumors, Carcinoma Neuroendocrine Skin. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III, Neuroendocrine Tumors, Carcinoma Neuroendocrine Skin
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- ACTIVE_NOT_RECRUITING
- Study Identifier
- NCTNCT04291885 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
Where Is This Clinical Trial Located?
This study is enrolling participants at 20 locations. Find a study site near you:
Clinical Research Site
Port Macquarie, New South Wales 2444 - Australia
Status: Contact for availability
Clinical Research Site
Sydney, New South Wales 2050 - Australia
Status: Contact for availability
Clinical Research Site
Sydney, New South Wales 2065 - Australia
Status: Contact for availability
Clinical Research Site
Sydney, New South Wales 2065 - Australia
Status: Contact for availability
Clinical Research Site
Sydney, New South Wales 2145 - Australia
Status: Contact for availability
Clinical Research Site
Sydney, New South Wales 2298 - Australia
Status: Contact for availability
Clinical Research Site
Wollongong, New South Wales 2500 - Australia
Status: Contact for availability
Clinical Research Site
Brisbane, Queensland 4029 - Australia
Status: Contact for availability
Clinical Research Site
Bundaberg, Queensland 4670 - Australia
Status: Contact for availability
Clinical Research Site
Cairns, Queensland 4870 - Australia
Status: Contact for availability
And 10 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III, Neuroendocrine Tumors, Carcinoma Neuroendocrine Skin:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial